Safety of Systemic Agents for the Treatment of Pediatric Psoriasis

IMPORTANCE: Use of systemic therapies for moderate to severe psoriasis in children is increasing, but comparative data on their use and toxicities are limited. OBJECTIVE: To assess patterns of use and relative risks of systemic agents for moderate to severe psoriasis in children. DESIGN, SETTING, AN...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Dermatol
Main Authors: Bronckers, Inge M. G. J., Seyger, Marieke M. B., West, Dennis P., Lara-Corrales, Irene, Tollefson, Megha, Tom, Wynnis L., Hogeling, Marcia, Belazarian, Leah, Zachariae, Claus, Mahé, Emmanuel, Siegfried, Elaine, Philipp, Sandra, Szalai, Zsuzsanna, Vleugels, Ruth Ann, Holland, Kristen, Murphy, Ruth, Baselga, Eulalia, Cordoro, Kelly, Lambert, Jo, Alexopoulos, Alex, Mrowietz, Ulrich, Kievit, Wietske, Paller, Amy S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710436/
https://ncbi.nlm.nih.gov/pubmed/28903160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2017.3029
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados